Metastatic neuroendocrine hepatic tumors: Resection improves survival

Archives of Surgery

Volumn 141, Issue 10, 2006, Pages 1000-1004

  Musunuru, Sandeepa ^a   Chen, Herbert ^a   Rajpal, Sharad ^a   Stephani, Nicholas ^b   McDermott, John C ^b   Holen, Kyle ^a   Rikkers, Layton F ^a   Weber, Sharon M ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; OCTREOTIDE;

ADULT; AGED; ARTERY SURGERY; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER TUMOR; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; TUMOR VOLUME;

ADENOMA, ISLET CELL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOID TUMOR; CATHETER ABLATION; DISEASE-FREE SURVIVAL; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; OCTREOTIDE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33750087253     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.10.1000     Document Type: Article

References (9)

1. Mansour JC, Chen H. Pancreatic endocrine tumors. J Surg Res. 2004;120:139-161.
2. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197:29-37.
3. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg. 1998;187:88-92.
4. Chamberlain RS, Canes D, Brown KT, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg. 2000;190:432-445.
5. Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery. 2003;134:1057-1063.
6. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg. 1995;169:36-42.
7. Grazi GL, Cescon M, Pierangeli F, et al. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology. 2000;47:481-486.
8. Nave H, Mossinger E, Feist H, Lang H, Raab H. Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery. 2001;129:170-175.
9. Knox CD, Feurer ID, Wise PE, et al. Survival and functional quality of life after resection for hepatic carcinoid metastasis. J Gastrointest Surg. 2004;8:653-659.